

Overview
Exploratory assessments of TAK-003 have been conducted to gain a holistic understanding of the immunogenicity of the live-attenuated dengue vaccine. In this e-Learning module, Dr Mayuri Sharma shares pertinent immunogenicity data for the TAK-003 vaccine and the ways in which the vaccine could address specific challenges associated with dengue infection. Dr Sharma works in Vaccine Research and Analytics at Takeda Vaccines. She leads research initiatives that support both dengue and Zika vaccine programmes.
Upon completing this module, participants will be able to: